89Bio Inc expected to post a loss of 64 cents a share - Earnings Preview

89bio

06/11/2024 04:33

* 89Bio Inc  ETNB.OQ   ETNB.O  is expected to show a rise in
quarterly revenue when it reports  results on November 7
(estimated) for the period ending September 30 2024
    * The San Francisco California-based  company is expected to
report revenue of $535.71 thousand, according to the mean
estimate from 7 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for 89Bio Inc is for a loss
of 64
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for 89Bio Inc
is
$29.50​, above​ its last closing price of $9.23. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.57       -0.57      -0.48     Beat    15.8
 Mar. 31 2024  -0.46       -0.46      -0.54     Missed  -17.1
 Jan. 1 0001   -0.48       -0.49      -0.50     Missed  -1​
 Sep. 30 2023  -0.53       -0.53      -0.45     Beat    15.1
 ​​Jun.        -0.42       -0.41      -0.52     Missed  -26.4
 30 2023                                                
 Mar. 31 2023  -0.48       -0.52      -0.54     Missed  -3.5​
 Jan. 1 0001   -0.68       -0.69      -0.48     Beat    30.1
 Sep. 30 2022  -0.82       -0.80      -0.57     Beat    28.5
 This summary was machine generated November 6 at 04:33 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)